Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting

Annals of Family Medicine

Volumn 6, Issue 5, 2008, Pages 390-396

  Dawes, Martin G ^a   Bartlett, Gillian ^a   Coats, Andrew J ^b   Juszczak, Edmund ^c  

^a MCGILL UNIVERSITY   (Canada)

^b University of Sydney   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ambulatory monitoring; Blood pressure; Family practice; Hypertension; Mortality; Practice based research; Primary care; White coat

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MONITORING; CAUSE OF DEATH; CHI SQUARE TEST; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GENERAL PRACTICE; GENERAL PRACTITIONER; HAZARD RATIO; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIMARY MEDICAL CARE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SEX RATIO; STUDENT T TEST; SUSTAINED HYPERTENSION; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; WHITE COAT HYPERTENSION;

EID: 54349090822     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.865     Document Type: Article

References (43)

1. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit. 2005;11(9):CR403-CR409.
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913.
3. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17(2):151-183.
4. Van Dongen HP, Maislin G, Kerkhof GA. Repeated assessment of the endogenous 24-hour profile of blood pressure under constant routine. Chronobiol Int. 2001;18(1):85-98.
5. Brennan PJ, Greenberg G, Miall WE, Thompson SG. Seasonal variation in arterial blood pressure. Br Med J (Clin Res Ed). 1982;285(6346):919-923.
6. Kay LE. Accuracy of blood pressure measurement in the family practice center. J Am Board Fam Pract. 1998;11(4):252-258.
7. Hessel PA. Terminal digit preference in blood pressure measurements: effects on epidemiological associations. Int J Epidemiol. 1986;15(1):122-125.
8. McCartney P, Crawford D. Inaccurate, leaky sphygmomanometers are still common. Br J Gen Pract. 2003;53(486):61-62.
9. Knight T, Leech F, Jones A, et al. Sphygmomanometers in use in general practice: an overlooked aspect of quality in patient care. J Hum Hypertens. 2001;15(10):681-684.
10. Bailey RH, Bauer JH. A review of common errors in the indirect measurement of blood pressure. Sphygmomanometry. Arch Intern Med. 1993;153(24):2741-2748.
11. Weber MA. Evaluating the diagnosis and prognosis of hypertension by automated blood pressure monitoring: outline of a symposium. Am Heart J. 1988;116(4):1118-1123.
12. Coats AJ, Conway J, Somers VK, Isea JE, Sleight P. Ambulatory pressure monitoring in the assessment of antihypertensive therapy. Cardiovasc Drugs Ther. 1989;1(Suppl 1):303-311.
13. Conway J, Coats A. Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens Suppl. 1989;7(3):S29-S32.
14. Shapiro AP, Karschner JK, Glunk DJ, Barnhill BM. Clinical use of ambulatory blood pressure monitoring. A review of value in patient care. Arch Fam Med. 1995;4(8):691-696.
15. Staessen JA, Fagard R, Lijnen P, et al. Ambulatory blood pressure and blood pressure measured at home: progress report on a population study. J Cardiovasc Pharmacol. 1994;23(5):S5-S11.
16. Prasad N, Isles C. Ambulatory blood pressure monitoring: a guide for general practitioners. BMJ. 1996;313(7071):1535-1541.
17. Taylor RS, Stockman J, Kernick D, Reinhold D, Shore AC, Tooke JE. Ambulatory blood pressure monitoring for hypertension in general practice. J R Soc Med. 1998;91(6):301-304.
18. Martinez MA, García-Puig J, Martín JC, et al. Frequency and determinants of white coat hypertension in mild to moderate hypertension: a primary care-based study. Monitorizacion Ambulatoria de la Presion Arterial (MAPA)-Area 5 Working Group. Am J Hypertens. 1999;12(3):251-259.
19. Pannarale G, Gaudio C, Cristina Acconcia M, Cuturello D. Results of antihypertensive treatment by primary and secondary care physicians as assessed by ambulatory blood pressure monitoring. Blood Press Monit. 2000;5(4):223-226.
20. Rugnath T, Pillay BJ, Cassimjee MH. Twenty-four hour ambulatory blood pressure monitoring in general practice. S Afr Med J. 2000;90(9):898-904.
21. Gardner SF, Schneider EF. 24-Hour ambulatory blood pressure monitoring in primary care. J Am Board Fam Pract. 2001;14(3):166-171.
22. Myers MG, Tobe SW, McKay DW, et al. New algorithm for the diagnosis of hypertension. Am J Hypertens. 2005;18(10):1369-1374.
23. Dawes MG, Coats AJ, Juszczak E. Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure. Blood Press Monit. 2006;11(3):111-118.
24. Verdecchia P, Reboldi G, Porcellati C, et al. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol. 2002;39(5):878-885.
25. Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens. 1997;15(4):357-364.
26. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249(20):2792-2798.
27. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259(2):225-228.
28. Hoegholm A, Kristensen KS, Madsen NH, Svendsen TL. White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients. Am J Hypertens. 1992;5(2):64-70.
29. Verdecchia P, Porcellati C. Defining normal ambulatory blood pressure in relation to target organ damage and prognosis. Am J Hypertens. 1993;6(Pt 2):207S-210S.
30. Gustavsen PH, Høegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10 year follow up study. J Hum Hypertens. 2003;17(12):811-817.
31. Strandberg TE, Salomaa V. White coat effect, blood pressure and mortality in men: prospective cohort study. Eur Heart J. 2000;21(20):1714-1718.
32. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005;19(10):801-807.
33. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111(14):1777-1783.
34. Clark S, Hofmeyr GJ, Coats AJ, Redman CW. Ambulatory blood pressure monitoring during pregnancy: validation study of the TM-2420 monitor. Obstet Gynecol. 1991;77(1):152-155.
35. White WB, Pickering TG, Morganroth J, et al. A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens. 1991;4(11):890-896.
36. Kelly JJ, Hunyor SN, Ho KY. Evaluation of the reproducibility and accuracy of ambulatory blood pressure monitoring using the Takeda TM-2420 automated blood pressure monitor. Clin Exp Hypertens. 1993;15(2):271-287.
37. Hemmelgarn BR, McAlister FA, Grover S, et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I-Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2006;22(7):573-581.
38. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24(6):793-801.
39. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508-515.
40. Hansen TW, Kikuya M, Thijs L, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens. 2007;25(8):1554-1564.
41. Pickering TG, Harshfield GA, Devereux RB, Laragh JH. What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension. 1985;7(2):171-177.
42. MRC trial of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed). 1985;291(6488):97-104.
43. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context [review; see comments]. Lancet. 1990;335(8693):827-838.